Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Medical Device Experts(?)

Council Members in this Study Group: 257

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

What is a GLG Leader?
Patrick Joseph Igoe, Life Sciences Patent Attorney, Independent IP Litigation ConsultantPatrick Joseph Igoe
Life Sciences Patent Attorney
Independent IP Litigation Consultant

Patrick Joseph Igoe is a consultant and registered patent attorney in New York. His focus is patent issues throughout Life Sciences - for example, diagnostic/therapeutic assays; medical devices/imaging technologies; Rx antibiotics, biologics, drugs, and vaccines; and OTC medicines. His expertise includes...

Eric Gruff, PhD MBA, Principal, E4 ConsultingEric Gruff, PhD MBA
Principal
E4 Consulting

Eric Gruff, PhD, MBA, BS, is the Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has over 16 years of experience in the pharmaceutical and biotech sector, including leadership roles at Pfizer, Agouron Pharmaceuticals,...

Hany Salama, Director, Global Manufacturing and Pharmaceutical , Barrier TherapeuticsHany Salama
Director, Global Manufacturing and Pharmaceutical
Barrier Therapeutics

Hany Salama, ME, MBA, CPM, is the Director of Global Manufacturing and Pharmaceuticals at Barrier Therapeutics, Inc., New Jersey. He has global responsibilities for commercial planning, supply chain, and manufacturing operations for all clinical and marketed products. Mr. Salama is also responsible...

James O'Reilly
Volunteer Professor of Law
University of Cincinnati - CC

James O'Reilly is a Volunteer Professor of Law at University of Cincinnati, where he has counseled large and small drug, biotech, device and food firms since becoming a full time professor in 1998. Prof. O’Reilly’s 31 books and 137 articles have been widely cited, and as an FDA expert over many years...

Michael McNeely
Principal
Law Offices of Michael D. McNeely

Michael McNeely is in private practice in Washington, DC, where he provides antitrust counseling and representation. Mr. McNeely consults on the antitrust and antitrust agency aspects of mergers, generic drug approvals, telecommunications, patents, standard setting, and other topics. He also represents...

Anthony Catanach, Jr., Director, DI2 Associates, LLCAnthony Catanach, Jr.
Director
DI2 Associates, LLC

Anthony H. Catanach Jr., PhD, is a Professor in the Strategic Initiatives Group of the Villanova University School of Business. He also is a Director at DI2 Associates, a Pennsylvania based accounting and reporting consulting firm. Dr. Catanach has expertise in the areas of business risk management...

Scot Bradley Glasberg, MD, Attending Staff Physician, Lenox Hill HospitalScot Bradley Glasberg, MD
Attending Staff Physician
Lenox Hill Hospital

Scot Glasberg, MD, is a Cosmetic and Reconstructive Plastic Surgeon in private practice in New York. Dr. Glasberg is also an Attending Staff Physician at Lenox Hill and Manhattan Eye, Ear and Throat Hospitals. He holds numerous positions within national, regional, and local medical and specialty societies...

Martin Gold, Principal, Technology Access Partners, LLC Martin Gold
Principal
Technology Access Partners, LLC

Martin Gold, MBA, is the Founder and Principal of Technology Access Partners, LLC and eMedLearn, LLC in New York. He assists medical technology manufacturers and investors to assess and respond to the business and investment challenges related to reimbursement. Mr. Gold has experience in reimbursement,...

View all GLG Leaders in this Study Group

GLG NewsSMAnalyses by this Study Group's Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
No Company is Bullet-Proof Against Federal Contractor Risks | 06-10-2008
Analysis of: U.S. sues Honeywell over bullet-proof vests | www.latimes.com
Author: James O'Reilly, Volunteer Professor of Law, University of Cincinnati - CC

Product liability exposure of new materials makers can be severe, especially with fatal consequences of failures Internal memos re product problems can shoot company in the foot; prudent firms have a plan for controlling open-ended speculative memos in an instant-message environment Major PR and govt....

FDA: Chinese Manufacturer of Tainted Heparin Involved in Fraud. | 04-30-2008
Author: GLG Expert Contributor

First, and foremost, the only working link for this article can be found at: http://www.reuters.com/article/domesticNews/idUSWAT00934620080415?feedType=RSS&feedName=domesticNews Although there is no proof offered in the article to substantiate the suggestion of fraud, there is enough circumstantial...

FDA Fees Must Be Increased to Fund Inspection of Chinese Products. | 04-30-2008
Analysis of: FDA fees eyed to boost food, drug safety | www.usatoday.com
Author: GLG Expert Contributor

One only has to read about the Heparin debacle, which has killed, at least, 81 Americans, to realize that there is a serious issue with the quality of medicines produced in China.  Manufacturing of medical food and consumer goods in China is growing at such a rate, the Chinese government has neither...

Who to Blame for Waste in the Medical Industry? Who's on First? | 04-30-2008
Author: GLG Expert Contributor

It's easy to point fingers of blame and this article does that, very well.  According to the "annalysis" everybody is to blame.  And, they're right, everyone is to blame, but where the article fails is the authoris inability to point out a real solution to the problem of wasted dollars spent...

Anemia Drugs Have Been Abused for Profit! | 04-30-2008
Analysis of: WellPoint likely to follow FDA on anemia drugs | www.reuters.com
Author: GLG Expert Contributor

Over the last year, it has become clear that the over-use of anemia drugs for cancer and renal failure has become a problem.  The reason can be sumed up in one word, which is profit.

View All GLG News by members of this Study Group

GLG InstituteSM Seminars with this Study Group's Leaders(?)

Most Common Company Types:

  • Medical Device Manufacturer
  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Consultancy, Healthcare-Focused
  • Medical Device Consultancy
  • Individual/Small Consultancy
  • Academic Institution*
  • Law Firm (general practice/large)
  • Pharmaceuticals Manufacturer
  • Consultancy, Pharma-Focused
  • Strategic Management

Most Common Job Types:

  • President
  • Director
  • Owner
  • Principal
  • Physician - Attending Physician
  • Chief Executive Officer
  • Partner
  • Consultant

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics